Recommendations for Titration and Administration of Oral Semaglutide for the Treatment of Type 2 Diabetes during Ramadan

Background: Injectable glucagon-like peptide-1 receptor agonists (GLP-1RAs) are proven to be well tolerated and efficacious in people with type 2 diabetes mellitus (T2DM) fasting during Ramadan. The first oral GLP-1RA semaglutide, also indicated for the treatment of T2DM, has specific dosing instruc...

Full description

Bibliographic Details
Published in:Dubai Diabetes and Endocrinology
Main Author: Hassanein M.; Almansari A.; Ba-Essa E.; Alawadi F.F.; Elbadawi H.; Sahay R.K.; Malik R.; Abdul Ghani R.; Abusnana S.; Shaikh S.; Zainudin S.B.; Elhadd T.; Al Saleh Y.
Format: Review
Language:English
Published: S. Karger AG 2022
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85198014844&doi=10.1159%2f000527475&partnerID=40&md5=ae23fc9ac69a9da02608be1dbf55cbda